Home » Aging and Modern Day Medicare » Hair Loss Treatments According to various surveys conducted worldwide, over half of the male population are struck with baldness by the age of 50. It's been studied that 36% of US women between 40 and 49 suffer from hair loss too. It is one of the disconcerting facts about aging that needs a lot of attention. Baldness treatments or hair loss treatments have a huge industry amounting to US $1 billion annually. The number of hair loss victims has increased significantly over the years, mainly due to imbalanced diet and hectic lifestyle. Since the 1980s, drug therapies have provided with a realistic solution for hair loss.

There is a myth that baldness generates from the maternal side of the family. But scientific researches reveal that it can come from either side. It is not guaranteed that you won't be affected by male pattern baldness, even if your father or grandfather happens to have thick hair growth.

Hair loss treatments belong to the category of aging and modern day Medicare. Dihydrotestosterone (DHT), which is basically an active metabolite of the testosterone, is responsible for both male and female pattern baldness. Hair loss is caused as this hormone affects the receptors in the scalp. The primary concern pertaining to hair loss treatments is how to regenerate hair in follicles. This task requires a lot more medical expertise than foreclosing the aging of healthy and thick hair. Some of the products that have resulted in positive effects with regards to hair loss treatments are minoxidil and finasteride.

The likely treatments for hair loss focus on areas such as hair cloning or hair multiplication. This method involves extraction of the self-refilling follicle stem cells and multiplication of the extracted cells in the lab, before they are injected at micro level into the scalp.